Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Quizartinib> ?p ?o. }
Showing items 1 to 44 of
44
with 100 items per page.
- Quizartinib abstract "Quizartinib (AC220) is a small molecule receptor tyrosine kinase inhibitor that is currently under development by Ambit Biosciences for the treatment of acute myeloid leukaemia. Its molecular target is FLT3, also known as CD135 which is a proto-oncogene.Flt3 mutations are among the most common mutations in acute myeloid leukaemia due to internal tandem duplication of Flt3. The presence of this mutation is a marker of adverse outcome.".
- Quizartinib fdaUniiCode "7LA4O6Q0D3".
- Quizartinib iupacName "1-(5-(tert-Butyl)isoxazol-3-yl)-3-(4-(7-(2-morpholinoethoxy)benzo[d]imidazo[2,1-b]thiazol-2-yl)phenyl)urea".
- Quizartinib thumbnail Quizartinib.svg?width=300.
- Quizartinib wikiPageID "30389315".
- Quizartinib wikiPageRevisionID "602945077".
- Quizartinib hasPhotoCollection Quizartinib.
- Quizartinib imagefile "Quizartinib.svg".
- Quizartinib imagesize "200".
- Quizartinib iupacname "1".
- Quizartinib othernames "AC220".
- Quizartinib unii "7".
- Quizartinib verifiedfields "changed".
- Quizartinib verifiedrevid "444260047".
- Quizartinib watchedfields "changed".
- Quizartinib subject Category:Isoxazoles.
- Quizartinib subject Category:Morpholines.
- Quizartinib subject Category:Receptor_tyrosine_kinase_inhibitors.
- Quizartinib subject Category:Ureas.
- Quizartinib type Abstraction100002137.
- Quizartinib type Chemical114806838.
- Quizartinib type Compound114818238.
- Quizartinib type Material114580897.
- Quizartinib type Matter100020827.
- Quizartinib type OrganicCompound114727670.
- Quizartinib type Part113809207.
- Quizartinib type PhysicalEntity100001930.
- Quizartinib type Relation100031921.
- Quizartinib type Substance100019613.
- Quizartinib type Urea115085472.
- Quizartinib type Ureas.
- Quizartinib type ChemicalCompound.
- Quizartinib type ChemicalSubstance.
- Quizartinib type ChemicalObject.
- Quizartinib type Thing.
- Quizartinib comment "Quizartinib (AC220) is a small molecule receptor tyrosine kinase inhibitor that is currently under development by Ambit Biosciences for the treatment of acute myeloid leukaemia. Its molecular target is FLT3, also known as CD135 which is a proto-oncogene.Flt3 mutations are among the most common mutations in acute myeloid leukaemia due to internal tandem duplication of Flt3. The presence of this mutation is a marker of adverse outcome.".
- Quizartinib label "Quizartinib".
- Quizartinib sameAs m.0g5q__m.
- Quizartinib sameAs Q7272714.
- Quizartinib sameAs Q7272714.
- Quizartinib sameAs Quizartinib.
- Quizartinib wasDerivedFrom Quizartinib?oldid=602945077.
- Quizartinib depiction Quizartinib.svg.
- Quizartinib isPrimaryTopicOf Quizartinib.